New Drug Approvals

Home » Articles posted by DR ANTHONY MELVIN CRASTO Ph.D (Page 397)

Author Archives: DR ANTHONY MELVIN CRASTO Ph.D

DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Blog Stats

  • 4,818,923 hits

Flag and hits

Flag Counter

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 37.9K other subscribers
Follow New Drug Approvals on WordPress.com

Archives

Categories

Recent Posts

Flag Counter

ORGANIC SPECTROSCOPY

Read all about Organic Spectroscopy on ORGANIC SPECTROSCOPY INTERNATIONAL 

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 37.9K other subscribers
DR ANTHONY MELVIN CRASTO Ph.D

DR ANTHONY MELVIN CRASTO Ph.D

DR ANTHONY MELVIN CRASTO, Born in Mumbai in 1964 and graduated from Mumbai University, Completed his Ph.D from ICT, 1991,Matunga, Mumbai, India, in Organic Chemistry, The thesis topic was Synthesis of Novel Pyrethroid Analogues, Currently he is working with AFRICURE PHARMA, ROW2TECH, NIPER-G, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India as ADVISOR, earlier assignment was with GLENMARK LIFE SCIENCES LTD, as CONSUlTANT, Retired from GLENMARK in Jan2022 Research Centre as Principal Scientist, Process Research (bulk actives) at Mahape, Navi Mumbai, India. Total Industry exp 32 plus yrs, Prior to joining Glenmark, he has worked with major multinationals like Hoechst Marion Roussel, now Sanofi, Searle India Ltd, now RPG lifesciences, etc. He has worked with notable scientists like Dr K Nagarajan, Dr Ralph Stapel, Prof S Seshadri, etc, He did custom synthesis for major multinationals in his career like BASF, Novartis, Sanofi, etc., He has worked in Discovery, Natural products, Bulk drugs, Generics, Intermediates, Fine chemicals, Neutraceuticals, GMP, Scaleups, etc, he is now helping millions, has 9 million plus hits on Google on all Organic chemistry websites. His friends call him Open superstar worlddrugtracker. His New Drug Approvals, Green Chemistry International, All about drugs, Eurekamoments, Organic spectroscopy international, etc in organic chemistry are some most read blogs He has hands on experience in initiation and developing novel routes for drug molecules and implementation them on commercial scale over a 32 PLUS year tenure till date Feb 2023, Around 35 plus products in his career. He has good knowledge of IPM, GMP, Regulatory aspects, he has several International patents published worldwide . He has good proficiency in Technology transfer, Spectroscopy, Stereochemistry, Synthesis, Polymorphism etc., He suffered a paralytic stroke/ Acute Transverse mylitis in Dec 2007 and is 90 %Paralysed, He is bound to a wheelchair, this seems to have injected feul in him to help chemists all around the world, he is more active than before and is pushing boundaries, He has 100 million plus hits on Google, 2.5 lakh plus connections on all networking sites, 100 Lakh plus views on dozen plus blogs, 227 countries, 7 continents, He makes himself available to all, contact him on +91 9323115463, email amcrasto@gmail.com, Twitter, @amcrasto , He lives and will die for his family, 90% paralysis cannot kill his soul., Notably he has 38 lakh plus views on New Drug Approvals Blog in 227 countries......https://newdrugapprovals.wordpress.com/ , He appreciates the help he gets from one and all, Friends, Family, Glenmark, Readers, Wellwishers, Doctors, Drug authorities, His Contacts, Physiotherapist, etc He has total of 32 International and Indian awards

Verified Services

View Full Profile →

Archives

Categories

Flag Counter

Swedish pharmaceutical company Moberg Pharma has completed enrolling patients in the ongoing Phase II trial of MOB-015 for the treatment of nail fungus (onychomycosis).


Links

http://clinicaltrials.pharmaceutical-business-review.com/news/moberg-completes-enrolling-onychomycosis-patients-in-phase-ii-trial-of-mob-015-270513

CFDA Approves Clinical Trials for Novel China AIDS Treatment, Azi Fu (Azvudine)


A novel treatment for AIDS, developed in the Zhengzhou University labs of Junbiao Chang, PhD, has been approved by the CFDA for human trials. The molecule, which has been in development for ten years, is a reverse transcriptase (RT) inhibito, called Azi Fu (Azvudine). According to Dr. Chang, Azi Fu is more effective at blocking the mutated forms of the virus than currently available treatments. He also believes the molecule has the potential to lower treatment costs

read all at

Links

http://www.chinabiotoday.com/articles/20130523

Parents network-www.fumuqin.comread at

Links

http://www.fumuqin.com/InfoFiles/007050004/63250-82263.html

DRUGS-PROCESS CHEMISTRY OVERVIEW


Links

http://www.slideshare.net/anthonycrasto64/process-research-overview

SEE MY PRESENTATION

DRUG MANUFACTURING PRESENTATION-PROCESSES


Links

http://www.slideshare.net/anthonycrasto64/anthony-crasto-manufacturing-presentation

SEE MY PRESENTATION

Norwegian researchers develop nano-needles


Pint-sized nail bed: a thin copper plate goes into the oven and out come needles that will force cells to accept the drug. Photo: NTNU

Links

http://www.manufacturingchemist.com/news/article_page/Norwegian_researchers_develop_nanoneedles/88641/cn48579?dm_i=8EU,1IFCK,9ETTTY,55585,1

Growing new brains with infrared light


Illustration of the “neuronal beacon” for guiding axon growth direction (credit: B. Black et al./Optics Letters)


Growing new brains with infrared light

Links

 http://www.kurzweilai.net/growing-new-brains-with-infrared-light?utm_source=KurzweilAI+Daily+Newsletter&utm_campaign=0307f9a402-UA-946742-1&utm_medium=email&utm_term=0_6de721fb33-0307f9a402-282116853

    University of Texas Arlington scientists have discovered a way to control the growth or repair of neurons and neuron circuits, using a non-invasive “neuronal beacon” (near-IR laser beam) — essentially rewiring brains, or even creating new ones. This major discovery, just published in Optics Letters, promises to enable several new applications, UT Arlington assistant professor … more…

Roche wins FDA approval for novel diabetes Dx


Roche’s next-generation diabetes diagnostic works on the Cobas Integra 800 analyzer. –Courtesy of Roche

Read more: Roche wins FDA approval for novel diabetes Dx – FierceMedicalDevices

Links

http://www.fiercemedicaldevices.com/story/roche-wins-fda-approval-novel-diabetes-dx/2013-05-24#ixzz2USeoTa9T

AbbVie and Eisai Announce HUMIRA® Pre-filled Syringe Has Received Approval for the Treatment of Intestinal Behçet’s Disease in Japan


Links

read all

http://www.pharmaintellect.com/2013/05/abbvie-and-eisai-announce-humira-pre.html?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+Pharmainvest+%28PharmaInvest%29

China’s Curative Medical to Seek CFDA Approval for ALung’s Respiratory Device


Links

http://www.chinabiotoday.com/articles/20130522

CFDA Approves Clinical Trials for Novel China AIDS Treatment


Links

http://www.chinabiotoday.com/articles/20130523